Sunday, July 5, 2026

Pharmaceutical Regulatory Affairs

Regulatory Affairs Tools

PDUFA, rNPV, patents, FDA submission guides, and ICH reference for RA professionals.

Quick Answer

NovaPharmaNews regulatory affairs tools help RA professionals estimate PDUFA dates, model rNPV and patent expiry, compare NDA vs ANDA pathways, and navigate FDA and ICH submission requirements — free, with no login.

Regulatory affairs professionals navigate complex submission requirements across FDA, EMA, and ICH frameworks. These free pharmaceutical tools provide quick-reference guides, pathway finders, and structured calculators for RA specialists, CMC scientists, and regulatory operations teams working on NDAs, ANDAs, BLAs, INDs, and international submissions.

Available Regulatory Affairs Tools

Frequently Asked Questions

This hub includes PDUFA date and calendar tools, rNPV calculator, patent expiry and exclusivity calculators, FDA submission type guides, eCTD structure reference, IND guide, EU GMP overview, regulatory pathway finder, and NDA vs ANDA comparison.
Enter the FDA filing or acceptance date and review type (standard, priority, etc.). The calculator applies published PDUFA review clock assumptions to estimate an action-date target. Confirm against the latest FDA CDER/CBER performance goals and the official action letter.
Risk-adjusted net present value (rNPV) discounts expected pipeline cash flows by phase-specific probability of success. Use it for portfolio prioritization, licensing discussions, and early business development modeling — not as a substitute for audited financial models.
The patent expiry calculator models nominal term plus common PTA/PTE adjustments for planning. Legal FTO and litigation decisions require counsel review of actual patent records, terminal disclaimers, and Orange Book listings.
The FDA Submission Types Guide explains NDA, ANDA, BLA, IND, and 505(b)(2) pathways. The Regulatory Pathway Finder matches drug type to likely FDA/EMA routes. The NDA vs ANDA comparison table summarizes requirements side by side.
Several guides cover EU GMP, ICH guidelines, and MAA timeline planning. FDA-specific tools (PDUFA, Orange Book-style exclusivity) should be paired with EMA EPAR and EU regulatory references for European filings.
No. All regulatory affairs tools on NovaPharmaNews are free with no login or subscription.
Regulatory tools complement our FDA and EMA news coverage. Use the PDUFA calendar alongside approval articles for context on upcoming action dates and pipeline assets.